J
Judy Garber
Researcher at Harvard University
Publications - 825
Citations - 88087
Judy Garber is an academic researcher from Harvard University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 147, co-authored 756 publications receiving 79157 citations. Previous affiliations of Judy Garber include Brigham and Women's Hospital & Georgia Regents University.
Papers
More filters
Journal ArticleDOI
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.
Richard Fishel,Mary Kay Lescoe,M.R.S. Rao,Neal G. Copeland,Nancy A. Jenkins,Judy Garber,Michael F. Kane,Richard D. Kolodner +7 more
TL;DR: Data and reports indicating that S. cerevisiae msh2 mutations cause an instability of dinucleotide repeats like those associated with H NPCC suggest that hMSH2 is the HNPCC gene.
Journal ArticleDOI
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
Andrew Tutt,Mark E. Robson,Judy Garber,Susan M. Domchek,M. William Audeh,Jeffrey N. Weitzel,Michael Friedlander,Banu Arun,Niklas Loman,Rita K. Schmutzler,Andrew M Wardley,Gillian Mitchell,H. M. Earl,Mark Wickens,James Carmichael +14 more
TL;DR: Findings from this phase 2 study provide positive proof of concept of the efficacy and tolerability of genetically targeted treatment with olaparib in BRCA-mutated advanced ovarian cancer.
Journal ArticleDOI
Mutational Processes Molding the Genomes of 21 Breast Cancers
Serena Nik-Zainal,Ludmil B. Alexandrov,David C. Wedge,Peter Van Loo,Peter Van Loo,Peter Van Loo,Christopher Greenman,Christopher Greenman,Christopher Greenman,Keiran Raine,David T. Jones,Jonathan Hinton,John D Marshall,Lucy Stebbings,Andrew Menzies,Sancha Martin,Kenric Leung,Lina Chen,Catherine Leroy,Manasa Ramakrishna,Richard Rance,King Wai Lau,Laura Mudie,Ignacio Varela,David J. McBride,Graham R. Bignell,Susanna L. Cooke,Adam Shlien,John Gamble,Ian Whitmore,Mark Maddison,Patrick S. Tarpey,Helen Davies,Elli Papaemmanuil,Philip J. Stephens,Stuart McLaren,Adam Butler,Jon W. Teague,Göran Jönsson,Judy Garber,Daniel P. Silver,Penelope Miron,Aquila Fatima,Sandrine Boyault,Anita Langerød,Andrew Tutt,John W.M. Martens,Samuel Aparicio,Åke Borg,Anne Vincent Salomon,Gilles Thomas,Anne Lise Børresen-Dale,Anne Lise Børresen-Dale,Andrea L. Richardson,Michael S. Neuberger,P. Andrew Futreal,Peter J. Campbell,Peter J. Campbell,Peter J. Campbell,Michael R. Stratton +59 more
TL;DR: This work generated catalogs of somatic mutation from 21 breast cancers and applied mathematical methods to extract mutational signatures of the underlying processes, finding a remarkable phenomenon of localized hypermutation, termed “kataegis,” was observed.
Journal ArticleDOI
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer
Andrew Tutt,Mark E. Robson,Judy Garber,Susan M. Domchek,M. W. Audeh,J. N. Weitzel,Michael Friedlander,B. K. Arun,Niklas Loman,Rita K. Schmutzler,Andrew M Wardley,Gillian Mitchell,H. M. Earl,Mark Wickens,J. Carmichael +14 more
TL;DR: The results of this study provide positive proof of concept for PARP inhibition in BRCA-deficient breast cancers and shows a favourable therapeutic index for a novel targeted treatment strategy in patients with tumours that have genetic loss of function of BRCa1-associated orBRCA2-associated DNA repair.
Journal ArticleDOI
Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations
Timothy R. Rebbeck,Henry T. Lynch,Susan L. Neuhausen,Steven A. Narod,Laura J. van't Veer,Judy Garber,Gareth Evans,Claudine Isaacs,Mary B. Daly,Ellen T. Matloff,Olufunmilayo I. Olopade,Barbara L. Weber +11 more
TL;DR: Bilateral prophylactic oophorectomy reduces the risk of coelomic epithelial cancer and breast cancer in women with BRCA1 or BRCa2 mutations.